Teva announces management succession
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb,…
1 January 2012 | By Teva
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as President and CEO...
List view / Grid view
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb,…
1 January 2012 | By Teva
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as President and CEO...
Teva will acquire all of the outstanding shares of Cephalon…
2 May 2011 | By Cephalon, Inc.
Teva will acquire all of the outstanding shares of Cephalon for a total enterprise value of approximately $6.8 billion...